Misplaced Pages

#241758

57-573: CIP/KIP family proteins bind a wide range of G1/S and S-phase cyclin-CDK complexes including cyclin D-CDK4,6 and cyclin E-, A-CDK2 complexes. Traditionally it was assumed that CIP/KIP proteins played a role in inhibiting all of these complexes; however it was later discovered that CIP/KIP proteins, while inhibiting CDK2 activity, may also activate cyclin D-CDK4,6 activity by facilitating stable binding between cyclin D and CDK4,6. The crystal structure of p27 in

114-470: A D-type cyclin (ORF72) that binds CDK6 and is likely to contribute to KSHV-related cancers. Cyclins are generally very different from each other in primary structure, or amino acid sequence. However, all members of the cyclin family are similar in 100 amino acids that make up the cyclin box. Cyclins contain two domains of a similar all-α fold , the first located at the N-terminus and the second at

171-518: A chromosome pair) have acquired new functions in order to manipulate the host cell's metabolism to the viruses’ benefit. Viral cyclin D binds human Cdk6 and inhibits Rb by phosphorylating it, resulting in free transcription factors which result in protein transcription that promotes passage through G1 phase of the cell cycle. Other than Rb, viral cyclin D-Cdk6 complex also targets p27 , a Cdk inhibitor of cyclin E and A. In addition, viral cyclin D-Cdk6

228-517: A complex with Cdk 4 or 6. One of the best known substrates of cyclin D/Cdk4 and -6 is the retinoblastoma tumor suppressor protein ( Rb ). Rb is an important regulator of genes responsible for progression through the cell cycle, in particular through G1/S phase. One model proposes that cyclin D quantities, and thus cyclin D- Cdk4 and -6 activity, gradually increases during G1 rather than oscillating in

285-572: A complex with cyclinA-CDK2 was published in 1996. The structure shows that p27 interacts with both cyclin A and CDK2. In addition, p27 mimics ATP and inserts itself into the ATP binding site thus preventing ATP binding. This mechanism blocks any kinase activity and prevents downstream hyper-phosphorylation of Rb that allows release of the E2F transcription factor and transcription of cell cycle-related genes. Cyclin D has low affinity for its CDK. Therefore, it

342-572: A delay in cell cycle entry and thus, cells with variants in cyclin D have bigger than normal cell size at cell division. p27 / knockout phenotype show an overproduction of cells because cyclin D is not inhibited anymore, while p27 / and cyclin D / knockouts develop normally. Cyclin Cyclins are proteins that control the progression of a cell through the cell cycle by activating cyclin-dependent kinases (CDK). Cyclins were originally discovered by R. Timothy Hunt in 1982 while studying

399-596: A modest effect in G1 progression. Cyclin D-Cdk 4,6 complexes target Rb for phosphorylation through docking a C-terminal helix. When the final 37 amino acid residues are truncated, it had previously been shown that Rb phosphorylation levels are reduced and G1 arrest is induced. Kinetic assays have shown that with the same truncation, the reduction of Rb phosphorylation by cyclin D1-Cdk4,6 is 20 fold and Michaelis-Menten constant (Km)

456-841: A p53-independent manner. Another way in which DNA damage targets Cdks is p53 -dependent induction of p21, which inhibits cyclin E-Cdk2 complex. In healthy cells, wild-type p53 is quickly degraded by the proteasome. However, DNA damage causes it to accumulate by making it more stable. A simplification in yeast is that all cyclins bind to the same Cdc subunit, the Cdc28. Cyclins in yeast are controlled by expression, inhibition via CKIs like Far1, and degradation by ubiquitin -mediated proteolysis . Given that many human cancers happen in response to errors in cell cycle regulation and in growth factor dependent intracellular pathways, involvement of cyclin D in cell cycle control and growth factor signaling makes it

513-532: A possible oncogene . In normal cells overproduction of cyclin D shortens the duration of G1 phase only, and considering the importance of cyclin D in growth factor signaling, defects in its regulation could be responsible for absence of growth regulation in cancer cells. Uncontrolled production of cyclin D affects amounts of cyclin D-Cdk4 complex being formed, which can drive the cell through the G0/S checkpoint, even when

570-454: A set pattern as do S and M cyclins. This happens in response to sensors of external growth-regulatory signals and cell growth, and Rb is phosphorylated as a result. Rb reduces its binding to E2F and thereby allows E2F-mediated activation of the transcription of cyclin E and cyclin A, which bind to Cdk1 and Cdk2 respectively to create complexes that continue with Rb phosphorylation. Cyclin A and E dependent kinase complexes also function to inhibit

627-1170: A stress-related kinase, and block its activity, protecting against JNK1-regulated apoptosis. CIP/KIP proteins can regulate transcription indirectly through stabilization of cyclinD-CDK and uninhibiting cyclin-CDK2 complexes that are crucial for Rb phosphorylation and release of the E2F transcription factor. CIP/KIP proteins have also been shown to directly bind transcription factors. For example. p27 has been shown to bind to and stabilize Neurogenin-2 promoting differentiation of neural progenitor cells. CIP/KIP proteins have previously been shown to inhibit Rho / ROCK /LIMK/ Cofilin signaling. In addition, fibroblasts deficient for p27 have reduced motility. p27 deficient fibroblasts also have increased levels of stress fibers and focal adhesions. The role of CIP/KIP proteins in motility has also become particularly of interest in cancer where misregulation of p27 could result in increased proliferation and increased motility which may contribute to more invasive cancers. As cyclin-dependent kinase inhibitors, CIP/KIP proteins have been classically viewed as tumor suppressors ; however,

SECTION 10

#1732782462242

684-435: A variety of mechanisms. p21 and p27 cleavage are known to promote apoptosis through activation of CDK2 activation. p57 has also been shown to inhibit apoptosis as p57 null mice show a range of developmental defects including cleft palate and a range of intestinal abnormalities associated with increased apoptosis. CIP/KIP proteins have also been shown to regulate apoptosis via CDK-independent mechanisms. p57 can bind JNK1/SAPK ,

741-623: Is a member of the cyclin protein family that is involved in regulating cell cycle progression. The synthesis of cyclin D is initiated during G1 and drives the G1/S phase transition . Cyclin D protein is anywhere from 155 (in zebra mussel ) to 477 (in Drosophila ) amino acids in length. Once cells reach a critical cell size (and if no mating partner is present in yeast) and if growth factors and mitogens (for multicellular organism) or nutrients (for unicellular organism) are present, cells enter

798-507: Is critical in the following roles (1) promoting the G1/S transition (2) allowing Rb dissociation from chromatin, and (3) E2F1 activation. Cyclin D is regulated by the downstream pathway of mitogen receptors via the Ras/MAP kinase and the β-catenin -Tcf/ LEF pathways and PI3K . The MAP kinase ERK activates the downstream transcription factors Myc, AP-1 and Fos which in turn activate

855-414: Is induced as a result of gene amplification, growth factor or oncogene induced expression by Src, Ras, ErbB2, STAT3, STAT5, impaired protein degradation, or chromosomal translocation. Gene amplification is responsible for overproduction of cyclin D protein in bladder cancer and esophageal carcinoma , among others. In cases of sarcomas , colorectal cancers and melanomas , cyclin D overproduction

912-520: Is lost. When Rb is mutated, levels of cyclin D and p16INK4 are normal. Another regulator of passage through G1 restriction point is Cdk inhibitor p16, which is encoded by INK4 gene. P16 functions in inactivating cyclin D/Cdk 4 complex. Thus, blocking transcription of INK4 gene would increase cyclin D/Cdk4 activity, which would in turn result in abnormal inactivation of Rb. On the other hand, in case of cyclin D in cancer cells (or loss of p16INK4) wild-type Rb

969-407: Is mono-phosphorylated during early to mid-G1by cyclin D-Cdk4,6, opposing the idea that its activity gradually increases. Cyclin D dependent monophosphorylated Rb still interacts with E2F transcription factors in a way that inhibits transcription of enzymes that drive the G1/S transition. Rather, E2F dependent transcription activity increases when that of Cdk2 increases and hyperphosphorylates Rb towards

1026-500: Is needed for Cdk binding and activation. The second five-helix bundle is composed of the same arrangement of helices, but the primary sequence of the two subdomains is distinct. All three D-type cyclins (D1, D2, D3) have the same alpha 1 helix hydrophobic patch. However, it is composed of different amino acid residues as the same patch in cyclins E, A, and B. Growth factors stimulate the Ras /Raf/ ERK that induce cyclin D production. One of

1083-577: Is not restricted to p21 and p27 and can also be performed by p57. The divergent role of CIP/KIP proteins based on whether they are bound to CDK2 or CDK4,6 has led to a model whereby CIP/KIP proteins bind to and inactivate CDK2 complexes in early G1; however, following production of Cyclin D, CIP/KIP proteins are removed and repurposed towards cyclin D-CDK stabilization. This sequestering then frees up Cyclin A-, E-CDK2 to hyperphosphorylate Rb and promote progression of

1140-547: Is noted, however, without the amplification of the chromosomal region that encodes it ( chromosome 11q 13, putative oncogene PRAD1 , which has been identified as a translocation event in case of mantle cell lymphoma ). In parathyroid adenoma , cyclin D hyper-production is caused by chromosomal translocation, which would place expression of cyclin D (more specifically, cyclin D1) under an inappropriate promoter , leading to overexpression. In this case, cyclin D gene has been translocated to

1197-920: Is one of the major cyclins produced in terms of its functional importance. It interacts with four Cdks: Cdk2 , 4 , 5 , and 6 . In proliferating cells, cyclin D-Cdk4/6 complex accumulation is of great importance for cell cycle progression. Namely, cyclin D-Cdk4/6 complex partially phosphorylates retinoblastoma tumor suppressor protein ( Rb ), whose inhibition can induce expression of some genes (for example: cyclin E ) important for S phase progression. Drosophila and many other organisms only have one cyclin D protein. In mice and humans, two more cyclin D proteins have been identified. The three homologues, called cyclin D1 , cyclin D2 , and cyclin D3 are expressed in most proliferating cells and

SECTION 20

#1732782462242

1254-448: Is resistant to Cdk inhibitors, such as p21 and p16 which in human cells inhibits Cdk4 by preventing it from forming an active complex with cyclin D. Cyclin D possesses a tertiary structure similar to other cyclins called the cyclin fold. This contains a core of two compact domains with each having five alpha helices. The first five-helix bundle is a conserved cyclin box, a region of about 100 amino acid residues on all cyclins, which

1311-491: Is retained. Due to the importance of p16INK/cyclin D/Cdk4 or 6/Rb pathway in growth factor signaling, mutations in any of the players involved can give rise to cancer. Studies with mutants suggest that cyclins are positive regulators of cell cycle entry. In yeast, expression of any of the three G1 cyclins triggers cell cycle entry. Since cell cycle progression is related to cell size, mutations in Cyclin D and its homologues show

1368-607: Is significantly increased. The phosphorylation of Rb by cyclin A-Cdk2, cyclin B-Cdk1, and cyclin E-Cdk2 are unaffected. The C terminus has a stretch of 21 amino acids with alpha-helix propensity. Deletion of this helix or disruption of it via proline residue substitutions also show a significant reduction in Rb phosphorylation. The orientation of the residues, along with the acid-base properties and polarities are all critical for docking. Thus,

1425-589: Is triggered by several cyclin-dependent kinase inhibitor protein (CKIs) like the INK4 family (e.g. p14 , p15 , p16 , p18 ). INK4 proteins are activated in response to hyperproliferative stress response that inhibits cell proliferation due to overexpression of e.g. Ras and Myc. Hence, INK4 binds to cyclin D- dependent CDKs and inactivates the whole complex. Glycogen synthase kinase three beta, GSK3β , causes Cyclin D degradation by inhibitory phosphorylation on threonine 286 of

1482-494: The C-terminus . All cyclins are believed to contain a similar tertiary structure of two compact domains of 5 α helices. The first of which is the conserved cyclin box, outside of which cyclins are divergent. For example, the amino-terminal regions of S and M cyclins contain short destruction-box motifs that target these proteins for proteolysis in mitosis. There are several different cyclins that are active in different parts of

1539-528: The growth factors are not present. Evidence that cyclin D1 is required for tumorigenesis includes the finding that inactivation of cyclin D1 by anti-sense or gene deletion reduced breast tumor and gastrointestinal tumor growth in vivo. Cyclin D1 overexpression is sufficient for the induction of mammary tumorigenesis, attributed to the induction of cell proliferation, increased cell survival, induction of chromosomal instability, restraint of autophagy and potentially non-canonical functions. Overexpression

1596-441: The parathyroid hormone gene, and this event caused abnormal levels of cyclin D. The same mechanisms of overexpression of cyclin D is observed in some tumors of the antibody -producing B cells . Likewise, overexpression of cyclin D protein due to gene translocation is observed in human breast cancer . Additionally, the development of cancer is also enhanced by the fact that retinoblastoma tumor suppressor protein (Rb), one of

1653-510: The Cdks to specific subcellular locations. Cyclins, when bound with the dependent kinases , such as the p34 / cdc2 / cdk1 protein, form the maturation-promoting factor . MPFs activate other proteins through phosphorylation . These phosphorylated proteins, in turn, are responsible for specific events during cell division such as microtubule formation and chromatin remodeling . Cyclins can be divided into four classes based on their behaviour in

1710-511: The Cyclin D protein. GSK3β is negatively controlled by the PI3K pathway in form of phosphorylation, which is one of several ways in which growth factors regulate cyclin D. Amount of cyclin D in the cell can also be regulated by transcriptional induction, stabilization of the protein, its translocation to the nucleus and its assembly with Cdk4 and Cdk6. It has been shown that the inhibition of cyclin D (cyclin D1 and 2, in particular) could result from

1767-455: The E3 ubiquitin ligase APC/C activating subunit Cdh1 through phosphorylation, which stabilizes substrates such as cyclin A. The coordinated activation of this sequence of interrelated positive feedback loops through cyclins and cyclin dependent kinases drives commitment to cell division to and past the G1/S checkpoint. Another model proposes that cyclin D levels remain nearly constant through G1. Rb

CIP/KIP - Misplaced Pages Continue

1824-510: The LxCxE, RxL, and helix docking sites all interact with different parts of cyclin D, but disruption of any two of the three mechanism can disrupt the phosphorylation of Rb in vitro. The helix binding, perhaps the most important, functions as a structural requirement. It makes evolving more difficult, leading the cyclin D-Cdk4/6 complex to have relatively small number of substrates relative to other cyclin-Cdk complexes. Ultimately this contributes to

1881-593: The Rb pocket domain, which has been shown to interact with proteins such as cyclin D and viral oncoproteins, has only a marginal 1.7 fold reduction in phosphorylation by cyclin D-Cdk4,6 when removed. Similarly, when the RxL motif, shown to interact with the S phase cyclins E and A, is removed, cyclin D-Cdk4,6 activity has a 4.1 fold reduction. Thus, the RxL- and LxCxE based docking sites have interactions with cyclin D-Cdk4,6 like they do with other cyclins, and removal of them have modest

1938-600: The adequate phosphorylation of a key target in Rb. All six cyclin D-Cdk4,6 complexes (cyclin D1/D2/D3 with Cdk4/6) target Rb for phosphorylation through helix-based docking. The shared α 1 helix hydrophobic patch that all cyclin D's have is not responsible for recognizing the C-terminal helix. Rather, it recognizes the RxL sequences that are linear, including those on Rb. Through experiments with purified cyclin D1-Cdk2, it

1995-414: The bi-oriented attachment of chromosomes to spindle microtubules through specialized structures called kinetochores. In the early phases of division, there are numerous errors in how kinetochores bind to spindle microtubules. The unstable attachments promote the correction of errors by causing a constant detachment, realignment and reattachment of microtubules from kinetochores in the cells as they try to find

2052-672: The cell cycle and that cause the Cdk to phosphorylate different substrates. There are also several "orphan" cyclins for which no Cdk partner has been identified. For example, cyclin F is an orphan cyclin that is essential for G 2 /M transition. A study in C. elegans revealed the specific roles of mitotic cyclins. Notably, recent studies have shown that cyclin A creates a cellular environment that promotes microtubule detachment from kinetochores in prometaphase to ensure efficient error correction and faithful chromosome segregation. Cells must separate their chromosomes precisely, an event that relies on

2109-411: The cell cycle of sea urchins. In an interview for "The Life Scientific" (aired on 13/12/2011) hosted by Jim Al-Khalili , R. Timothy Hunt explained that the name "cyclin" was originally named after his hobby cycling. It was only after the naming did its importance in the cell cycle become apparent. As it was appropriate the name stuck. R. Timothy Hunt : "By the way, the name cyclin, which I coined,

2166-544: The cell cycle of vertebrate somatic cells and yeast cells: G1 cyclins, G1/S cyclins, S cyclins, and M cyclins. This division is useful when talking about most cell cycles, but it is not universal as some cyclins have different functions or timing in different cell types. G1/S Cyclins rise in late G1 and fall in early S phase. The Cdk- G1/S cyclin complex begins to induce the initial processes of DNA replication, primarily by arresting systems that prevent S phase Cdk activity in G1. The cyclins also promote other activities to progress

2223-436: The cell cycle, such as centrosome duplication in vertebrates or spindle pole body in yeast. The rise in presence of G1/S cyclins is paralleled by a rise in S cyclins. G1 cyclins do not behave like the other cyclins, in that the concentrations increase gradually (with no oscillation), throughout the cell cycle based on cell growth and the external growth-regulatory signals. The presence of G cyclins coordinate cell growth with

2280-453: The cell cycle. This model is supported by the finding that expression of either wild-type or catalytically inactive CDK4 can sequester CIP/KIP proteins resulting in cyclin E-CDK2 activation. This finding suggests that the ability of cyclinD-CDK complexes to sequester CIP/KIP proteins is predominates their inhibitory activity of CDK2. CIP/KIP proteins have been shown to regulate apoptosis via

2337-473: The cell cycle. In general, all stages of the cell cycle are chronologically separated in humans and are triggered by cyclin- Cdk complexes which are periodically expressed and partially redundant in function. Cyclins are eukaryotic proteins that form holoenzymes with cyclin-dependent protein kinases (Cdk), which they activate. The abundance of cyclins is generally regulated by protein synthesis and degradation through APC/C - and CRL -dependent pathways. Cyclin D

CIP/KIP - Misplaced Pages Continue

2394-446: The complex is not formed at detectable levels. In eukaryotes, overexpression of translation initiation factor 4E ( eIF4E ) leads to an increased level of cyclin D protein and increased amount of cyclin D mRNA outside of the nucleus. This is because eIF4E promotes the export of cyclin D mRNAs out of the nucleus. Inhibition of cyclin D via inactivation or degradation leads to cell cycle exit and differentiation. Inactivation of cyclin D

2451-826: The correct attachment. Protein cyclin A governs this process by keeping the process going until the errors are eliminated. In normal cells, persistent cyclin A expression prevents the stabilization of microtubules bound to kinetochores even in cells with aligned chromosomes. As levels of cyclin A decline, microtubule attachments become stable, allowing the chromosomes to be divided correctly as cell division proceeds. In contrast, in cyclin A-deficient cells, microtubule attachments are prematurely stabilized. Consequently, these cells may fail to correct errors, leading to higher rates of chromosome mis-segregation. There are two main groups of cyclins: The specific cyclin subtypes along with their corresponding CDK (in brackets) are: In addition,

2508-470: The cyclins, namely fluctuations in cyclin gene expression and destruction by the ubiquitin mediated proteasome pathway, induce oscillations in Cdk activity to drive the cell cycle. A cyclin forms a complex with Cdk, which begins to activate, but the complete activation requires phosphorylation as well. Complex formation results in activation of the Cdk active site . Cyclins themselves have no enzymatic activity but have binding sites for some substrates and target

2565-743: The end of G1. Rb may not be the only target for cyclin D to promote cell proliferation and progression through the cell cycle. The cyclin D-Cdk4,6, complex, through phosphorylation and inactivation of metabolic enzymes, also influences cell survival. Through close analysis of different Rb-docking helices, a consensus helix sequence motif was identified, which can be utilized to identify potential non-canonical substrates that cyclin D-Cdk4,6 could use to promote proliferation. RxL- and LxCxE- based docking mutations broadly affect cyclin-Cdk complexes. Mutations of key Rb residues previously observed to be needed for Cdk complex docking interactions result in reduced overall kinase activity towards Rb. The LxCxE binding cleft in

2622-466: The entry to a new cell cycle. S cyclins bind to Cdk and the complex directly induces DNA replication. The levels of S cyclins remain high, not only throughout S phase, but through G2 and early mitosis as well to promote early events in mitosis. M cyclin concentrations rise as the cell begins to enter mitosis and the concentrations peak at metaphase. Cell changes in the cell cycle like the assembly of mitotic spindles and alignment of sister-chromatids along

2679-462: The exact role of CIP/KIP proteins in cancer progression has been difficult to assess because a complete loss of CIP/KIP function has not been observed in any cancers. However, low-expression p27 has been observed in a wide variety of tumors and is associated with increased tumor aggression. In addition, p27 null mice spontaneously develop tumors in the pituitary gland and are more susceptible to chemical carcinogens or irradiation. In particular, not only

2736-499: The expression of p27, but also the subcellular localization of p27 is thought to play an important role in tumorigenesis. Elevated cytoplasmic localization of p27 has been observed in a number of cancers and has been associated with a poor prognosis. This mislocalization could potentially explain how p27 could simultaneously promote cell cycle progression and increased motility in cancers. A similar model could also be equally true of other CIP/KIP proteins. Cyclin D Cyclin D

2793-601: The induction of WAF1/ CIP1 /p21 protein by PDT. By inhibiting cyclin D, this induction also inhibits Ckd2 and 6. All these processes combined lead to an arrest of the cell in G0/G1 stage. There are two ways in which DNA damage affects Cdks. Following DNA damage, cyclin D (cyclin D1) is rapidly and transiently degraded by the proteasome upon its ubiquitylation by the CRL4 - AMBRA1 ubiquitin ligase . This degradation causes release of p21 from Cdk4 complexes, which inactivates Cdk2 in

2850-458: The key substrates of cyclin D-Cdk 4/6 complex, is quite frequently mutated in human tumors . In its active form, Rb prevents crossing of the G1 checkpoint by blocking transcription of genes responsible for advances in cell cycle. Cyclin D/Cdk4 complex phosphorylates Rb, which inactivates it and allows for the cell to go through the checkpoint. In the event of abnormal inactivation of Rb, in cancer cells, an important regulator of cell cycle progression

2907-465: The members of the pathways, MAPK activates a transcription factor Myc , which alters transcription of genes important in cell cycle, among which is cyclin D. In this way, cyclin D is synthesized as long as the growth factor is present. Cyclin D levels in proliferating cells are sustained as long as the growth factors are present, a key player for G1/S transition is active cyclin D-Cdk4/6 complexes. Cyclin D has no effect on G1/S transition unless it forms

SECTION 50

#1732782462242

2964-444: The relative amounts expressed differ in various cell types. The most studied homologues of cyclin D are found in yeast and viruses . The yeast homologue of cyclin D, referred to as CLN3 , interacts with Cdc28 (cell division control protein) during G1. In viruses, like Saimiriine herpesvirus 2 ( Herpesvirus saimiri ) and Human herpesvirus 8 ( HHV-8 / Kaposi's sarcoma-associated herpesvirus ) cyclin D homologues (one member of

3021-587: The spindles are induced by M cyclin- Cdk complexes. The destruction of M cyclins during metaphase and anaphase, after the Spindle Assembly Checkpoint is satisfied, causes the exit of mitosis and cytokinesis. Expression of cyclins detected immunocytochemically in individual cells in relation to cellular DNA content (cell cycle phase), or in relation to initiation and termination of DNA replication during S-phase, can be measured by flow cytometry . Kaposi sarcoma herpesvirus ( KSHV ) encodes

3078-548: The transcription of the Cdk4 , Cdk6 and cyclin D genes, and increase ribosome biogenesis. Rho family GTPases , integrin linked kinase and focal adhesion kinase ( FAK ) activate cyclin D gene in response to integrin . p27 and p21 are cyclin-dependent kinase inhibitors ( CKIs ) which negatively regulate CDKs. However they are also promoters of the cyclin D-CDK4/6 complex. Without p27 and p21, cyclin D levels are reduced and

3135-582: Was concluded that the helix docking site likely lies on cyclin D rather than the Cdk4,6. As a result, likely another region on cyclin D recognizes the Rb C-terminal helix. Since Rb's C – terminal helix exclusively binds cyclin D-Cdk4,6 and not other cell cycle dependent cyclin-Cdk complexes, through experiments mutating this helix in HMEC cells, it has been conclusively shown that the cyclin D – Rb interaction

3192-723: Was hypothesized that additional proteins were needed to allow for a stable cyclin D-CDK4,6 complex. Growing evidence has shown that CIP/KIP proteins are involved in this stabilization. The first evidence of this came from the observation that p27 would frequently immunoprecipitate with active cyclin D-CDK4 complexes. Futhurmore, mouse embryonic fibroblasts deficient for p21 and p27 had lower levels of cyclin D1 and immunoprecipitated cyclinD-CDK complexes had no kinase activity. These effects were rescued with reintroduction of p21 and p27, but not reintroduction of cyclin D1 suggesting that CIP/KIP proteins are crucial for cyclin D-CDK activity. In vitro evidence has shown that cyclin D-CDK binding of CIP/KIP

3249-402: Was really a joke, it's because I liked cycling so much at the time, but they did come and go in the cell..." Cyclins were originally named because their concentration varies in a cyclical fashion during the cell cycle. (Note that the cyclins are now classified according to their conserved cyclin box structure, and not all these cyclins alter in level through the cell cycle. ) The oscillations of

#241758